From: Integrative analysis of gene expression and methylation data for breast cancer cell lines
 | # Hyper probes | % Hyper probes | # Hypo probes | % Hypo probes | # N/A | % N/A |
---|---|---|---|---|---|---|
MAX | 11 | 68.75% | 3 | 18.75% | 2 | 12.50% |
EGFR | 11 | 52.38% | 3 | 14.29% | 7 | 33.33% |
JUN | 24 | 58.54% | 2 | 4.88% | 15 | 36.59% |
FN1 | 8 | 80.00% | 1 | 10.00% | 1 | 10.00% |
FOXA1 | 38 | 52.05% | 13 | 17.80% | 22 | 30.14% |
MMP2 | 3 | 60.00% | 1 | 20.00% | 1 | 20.00% |
ELAVL1 | 2 | 33.33% | 2 | 33.33% | 2 | 33.33% |